Getinge AB ser. B (GETI-B.ST)

Getinge AB ser. B stock price today, ATLAS forecast and fair value

Healthcare · Medical Devices · Nasdaq Stockholm · Sweden

SEK 268.00▲ +0.11%

Prices as of Oct 26, 2026 · SEK

ATLAS fair value

SEK 403.20

Below fair value · 34% discount

Chance of rising in 1 month

54%

that it ends higher than today in 21 sessions

0%coin flip 50%100%

This is just the summary. See everything on Getinge AB ser. B in ATLAS

ATLAS's own quantitative analysis, all in one place.

  • Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
  • Officers and shareholdersWho runs the company and which funds hold its shares.
  • Customer and supplier mapWho it does business with, from its own filings.
  • ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
  • AlertsWe let you know when something changes in your stocks.
See everything included
  • Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
  • NewsThe latest on the company, in one place.
  • Crisis simulatorHow your portfolio would do in a crash like 2008.
  • Practice risk-free$10,000 in virtual money to invest at real prices.
  • Global screenerSearch US stocks and stocks from 47 countries with filters.

On Getinge AB ser. B

  • Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
  • Officers and shareholdersWho runs the company and which funds hold its shares.
  • Customer and supplier mapWho it does business with, from its own filings.
  • Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
  • NewsThe latest on the company, in one place.

And for you

  • ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
  • AlertsWe let you know when something changes in your stocks.
  • Crisis simulatorHow your portfolio would do in a crash like 2008.
  • Practice risk-free$10,000 in virtual money to invest at real prices.
  • Global screenerSearch US stocks and stocks from 47 countries with filters.
Get started →

Plans from €3.99 a month.

ATLAS estimates Getinge AB ser. B's fair value at about SEK 403.20 per share (reasonable range: SEK 269.39 to SEK 558.93). At SEK 268.00, the stock trades 34% below it.

It is calculated with a blend of a discounted cash-flow model and peer valuation multiples. Confidence in the estimate is high. It is an estimate, not a promise: if the company's results change, so does its fair value.

ATLAS's model gives Getinge AB ser. B a 54% chance of finishing higher a month from now (21 trading sessions) than today: close to a coin flip.

In half of the simulated outcomes the price ends between SEK 260.29 and SEK 278.30; in 9 out of 10, between SEK 245.29 and SEK 295.31. Estimated annual volatility is 15%.

Price, last 12 months (weekly close)

Getinge AB ser. B (GETI-B.ST) — Price, last 12 months (weekly close)Oct 24, 2025: SEK 222.70. Oct 26, 2026: SEK 268.00. ▲SEK 268.00SEK 180.60Oct 24, 2025Oct 26, 2026

Key numbers

Market cap
SEK 69.7B
Market cap (USD)
$7.0B
P/E ratio
25.5
Dividend yield
1.79%
52-week high
SEK 270.00
52-week low
SEK 175.90
Revenue (12 months)
SEK 34.5B
Gross margin
49.0%
Operating margin
13.5%
Net margin
8.2%
Beta
0.82

What this means

These are two different questions: fair value looks at the business (what it is worth given what it earns) and the odds look at the price over the next month. Getinge AB ser. B sits below fair value and its odds of rising over a month are close to a coin flip. An expensive stock can keep climbing and a cheap one can keep falling, which is why ATLAS shows the two readings separately.

Over the last 52 weeks GETI-B.ST has traded between SEK 175.90 and SEK 270.00. Today it is 0.7% below that high and 52% above its low.

On the business: net margin is 8.2%; it trades at 25.5 times earnings.

Its beta is 0.82: it tends to move less than the market.

About the company

Getinge AB (publ) provides products and solutions for operating rooms, intensive-care units, and sterilization departments in Sweden and internationally. The company operates through Acute Care Therapies, Life Science, and Surgical Workflows segments.

Want to see everything about Getinge AB ser. B?

Get started →

Plans from €3.99 a month.

Comparable companies

Other companies in the same line of business:

Frequently asked questions

What is Getinge AB ser. B (GETI-B.ST) fair value?

About SEK 403.20 per share according to ATLAS (reasonable range: SEK 269.39 to SEK 558.93). With the stock at SEK 268.00, it is 34% below it.

What is the chance GETI-B.ST goes up next month?

54%: close to a coin flip. In half of the simulated outcomes, GETI-B.ST ends the month between SEK 260.29 and SEK 278.30.

How big is Getinge AB ser. B and what is its P/E ratio?

Getinge AB ser. B's market capitalization is SEK 69.7B. Its price-to-earnings (P/E) ratio is 25.5: you pay SEK 25.5 for each SEK 1.00 of yearly earnings.

Does Getinge AB ser. B pay a dividend?

Yes. GETI-B.ST's current dividend yield is 1.79% at today's price (SEK 268.00).

Not investment advice. ATLAS estimates are produced by statistical models from public data; they can be wrong and past performance does not predict future results. Consider your own situation before investing. Disclaimer

ATLAS Signals

ATLAS Signals, every week

The week in the market, three stocks on ATLAS’s radar and what comes next. Get it every Monday.

By subscribing you agree to receive ATLAS Signals by email every Monday. You can unsubscribe with one click at any time. Privacy